GeneDx Holdings Corp. (WGS)
136.55
+0.75
(+0.55%)
USD |
NASDAQ |
Jan 07, 16:00
136.55
0.00 (0.00%)
After-Hours: 18:09
GeneDx Holdings Research and Development Expense (TTM): 57.94M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Illumina, Inc. | 967.00M |
| Labcorp Holdings, Inc. | -- |
| Quest Diagnostics, Inc. | -- |
| Guardant Health, Inc. | 359.47M |
| Delcath Systems, Inc. | 22.79M |